Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Ataxia-telangiectasia - A historical review and a proposal for a new designation: ATM syndrome
Ataxia and myoclonic epilepsy due to a heterozygous new mutation in KCNA2: proposal for a new channelopathy
Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III)
Ataxia and tremor due to lesions involving cerebellar projection pathways: a DTI tractographic study in six patients
Ataxia telangiectasia mutated inhibits oxidative stress-induced apoptosis by regulating heme oxygenase-1 expression
Ataxia at the Masquerade Ball
Ataxia induced by a thymic neuroblastoma in the elderly patient
Ataxin-2 Regulates RGS8 Translation in a New BAC-SCA2 Transgenic Mouse Model
Ataxia Telangiectasia Mutated Kinase Mediates NF-kappa B Serine 276 Phosphorylation and Interferon Expression via the IRF7-RIG-I Amplification Loop in Paramyxovirus Infection
Ataxin-2 expands insight into the ALS clinical spectrum
Ataxia telangiectasia
Ataxia Telangiectasia Mutated (ATM) Inhibition Transforms Human Mammary Gland Epithelial Cells
Ataxia and Progressive Encephalopathy in a 4-Year-Old Girl
Ataxias and cerebellar dysfunction: involvement of synaptic plasticity deficits?
Ataxin active site determination using spectral distribution of electron ion interaction potentials of amino acids
Ataxia with vitamin E deficiency: update of molecular diagnosis
Ataxia and the olivo-cerebellar module
Ataxia Telangiectasia Mutated (ATM)-mediated DNA Damage Response in Oxidative Stress-induced Vascular Endothelial Cell Senescence
Ataxia telangiectasia mutated nuclear localization in head and neck cancer cells is PPP2R2B-dependent
Ataxin-3 Plays a Role in Mouse Myogenic Differentiation through Regulation of Integrin Subunit Levels
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Ataxia-Telangiectasia in a Patient Presenting With Hyper-immunoglobulin M Syndrome
Ataxic gait analysis in a mouse model of the olivocerebellar degeneration
Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia
Ataxia, dystonia and myoclonus in adult patients with Niemann-Pick type C
Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity
Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction
Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L
Ataxia Severity Correlates with White Matter Degeneration in Spinocerebellar Ataxia Type 7
Ataxia telangiectasia mutated (ATM) interacts with p400 ATPase for an efficient DNA damage response
Ataxia with vitamin E deficiency caused by a new compound heterozygous mutation
Ataxia Telangiectasia Masquerading as Hyper IgM Syndrome
Ataxic gait following total gastrectomy for gastric cancer
Ataxia telangiectasia: a syndrome deserving attention and study
Ataxia Telangiectasia-Mutated Gene Polymorphisms and Acute Normal Tissue Injuries in Cancer Patients After Radiation Therapy: A Systematic Review and Meta-analysis
Ataxias with Autosomal, X-Chromosomal or Maternal Inheritance
Ataxia-telangiectasia and Rad3-related and DNA-dependent protein kinase cooperate in G(2) checkpoint activation by the DNA strand-breaking nucleoside analogue 2 '-C-cyano-2 '-deoxy-1-beta-D-arabino-pentofuranosylcytosine
Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to gnomic instability in iPS cells
Ataxia telangiectasia mutated- and Rad3-related kinase drives both the early and the late DNA-damage response to the monofunctional antitumour alkylator S23906
Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks
Ataxin-7 associates with microtubules and stabilizes the cytoskeletal network
Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis
Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts
Ataxia-telangiectasia-Mutated Protein Kinase Levels Stratify Patients With Pancreatic Adenocarcinoma Into Prognostic Subgroups With Loss Being a Strong Indicator of Poor Survival
Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle
Ataxia-telangiectasia and related diseases
Ataxia-telangiectasia-like disorder (ATLD) - its clinical presentation and molecular basis
Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor kappa Light Chain Enhancer of Activated B Cells (NF kappa B) Signaling Controls Basal and DNA Damage-induced Transglutaminase 2 Expression
Ataxin-1 and Brother of ataxin-1 are components of the Notch signalling pathway
Ataxin-1 occupies the promoter region of E-cadherin in vivo and activates CtBP2-repressed promoter
Ataxia with oculomotor apraxia: clinical-genetic characteristics and DNA-diagnostic
Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients
Ataxia
Ataxin-1 Poly(Q)-induced Proteotoxic Stress and Apoptosis Are Attenuated in Neural Cells by Docosahexaenoic Acid-derived Neuroprotectin D1
Ataxia telangiectasia-mutated damage-signaling kinase- and proteasome-dependent destruction of Mre11-Rad50-Nbs1 Subunits in simian virus 40-infected primate cells
Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis
Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage
Ataxia-telangiectasia, an evolving phenotype
Ataxia telangiectasia mutated expression and activation in the testis
Ataxia-telangiectasia Without ataxia or telangiectasia?
Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis
Ataxia-telangiectasia-mutated (ATM) is a T-antigen kinase that controls SV40 viral replication in vivo
Ataxia telangiectasia-mutated, a DNA damage-inducible kinase, contributes to high NaCl-induced nuclear localization of transcription factor TonEBP/OREBP
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
Ataxia telangiectasia-mutated-dependent DNA damage checkpoint functions regulate gene expression in human fibroblasts
Ataxia-telangiectasia and T-cell leukemias: No evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients
Ataxia-Telangiectasia Mutated and the Mre11-Rad50-NBS1 Complex: Promising Targets for Radiosensitization
Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage
Ataxia With Oculomotor Apraxia
Ataxia with oculomotor apraxia type 2: A clinical and genetic study of 19 patients
Ataxia telangiectasia-mutated protein and DNA-dependent protein kinase have complementary V(D)J recombination functions
Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells
Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients
Ataxia Telangiectasia Mutated Kinase Controls Chronic Gammaherpesvirus Infection
Ataxia telangiectasia: The consequences of a delayed diagnosis
Ataxia telangiectasia mutated influences cytochrome c oxidase activity
Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer (vol 9, pg 759, 2008)
Ataxia Telangiectasia in a Three-Year-Old-Girl
Ataxia-telangiectasia
Ataxia in posterior circulation stroke: Clinical-MRI correlations
Ataxia-telangiectasia mutated (ATM) genetic variant in Italian centenarians
Ataxia-Telangiectasia and Wilms Tumor: Reduced Treatment But Early Relapse